TW200745094A - ATM inhibitor - Google Patents
ATM inhibitorInfo
- Publication number
- TW200745094A TW200745094A TW095132010A TW95132010A TW200745094A TW 200745094 A TW200745094 A TW 200745094A TW 095132010 A TW095132010 A TW 095132010A TW 95132010 A TW95132010 A TW 95132010A TW 200745094 A TW200745094 A TW 200745094A
- Authority
- TW
- Taiwan
- Prior art keywords
- atm inhibitor
- atm
- inhibitor
- prodrugs
- solvates
- Prior art date
Links
- 239000012827 ATM inhibitor Substances 0.000 title 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71318705P | 2005-08-31 | 2005-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200745094A true TW200745094A (en) | 2007-12-16 |
Family
ID=37067637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095132010A TW200745094A (en) | 2005-08-31 | 2006-08-30 | ATM inhibitor |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070049588A1 (zh) |
| AR (1) | AR056049A1 (zh) |
| TW (1) | TW200745094A (zh) |
| UY (1) | UY29774A1 (zh) |
| WO (1) | WO2007026157A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008146036A1 (en) * | 2007-05-25 | 2008-12-04 | Astrazeneca Ab | Combination of checkponit kinase ( chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer |
| CA2779260A1 (en) * | 2009-11-10 | 2011-05-19 | Shell Internationale Research Maatschappij B.V. | Process for producing ethylene oxide |
| KR20140147797A (ko) | 2011-06-27 | 2014-12-30 | 더 잭슨 래보라토리 | 암 및 자가면역 질환의 치료 방법 및 조성물 |
| EP3042900B1 (en) * | 2013-08-29 | 2020-09-23 | Fujifilm Corporation | Novel morpholine derivative or salt thereof |
| KR102276424B1 (ko) | 2014-10-06 | 2021-07-12 | 삼성전자주식회사 | 로-키나제 저해제를 포함하는 세포의 노화를 감소시키기 위한 조성물 및 그의 용도 |
| KR20160049435A (ko) | 2014-10-27 | 2016-05-09 | 삼성전자주식회사 | Atm 저해제를 포함하는 세포의 노화를 감소시키기 위한 조성물 및 그의 용도 |
| WO2016130897A1 (en) | 2015-02-13 | 2016-08-18 | Yu Paul B | Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue |
| EP3112466A1 (en) | 2015-07-01 | 2017-01-04 | Samsung Electronics Co., Ltd. | Composition for reducing cellular senescence level including activity inhibitor inhibiting dcun1d3 activity or expression inhibitor inhibiting expression of dcun1d3-encoding gene and use thereof |
| CN109879855B (zh) * | 2019-03-26 | 2021-01-05 | 中国医学科学院医药生物技术研究所 | 靶向肿瘤细胞表面pd-l1分子的抑制剂及其应用 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025080946A2 (en) | 2023-10-12 | 2025-04-17 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025217307A1 (en) | 2024-04-09 | 2025-10-16 | Revolution Medicines, Inc. | Methods for predicting response to a ras(on) inhibitor and combination therapies |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0753725B2 (ja) * | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
| US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
| US5703075A (en) * | 1988-12-21 | 1997-12-30 | Pharmacia & Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| US5302613A (en) * | 1990-06-29 | 1994-04-12 | The Upjohn Company | Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones |
| US5252735A (en) * | 1990-06-29 | 1993-10-12 | The Upjohn Company | Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones |
| ATE203904T1 (de) * | 1993-04-09 | 2001-08-15 | Toyama Chemical Co Ltd | Immunomodulator, zelladhäsionsinhibitor und mittel zur behandlung und vorbeugung von autoimmunerkrankungen |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| US6387640B1 (en) * | 1999-02-10 | 2002-05-14 | St. Jude Children's Research Hospital | ATM kinase modulation for screening and therapies |
| US6348311B1 (en) * | 1999-02-10 | 2002-02-19 | St. Jude Childre's Research Hospital | ATM kinase modulation for screening and therapies |
| GB0119865D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| US7049313B2 (en) * | 2002-02-25 | 2006-05-23 | Kudos Pharmaceuticals Ltd. | ATM inhibitors |
| BR0307944A (pt) * | 2002-02-25 | 2005-02-01 | Kudos Pharm Ltd | Piranonas úteis como inibidores de atm |
| ES2357057T3 (es) * | 2002-04-30 | 2011-04-15 | Kudos Pharmaceuticals Limited | Derivados de ftalazinona. |
| ATE461193T1 (de) * | 2003-08-13 | 2010-04-15 | Kudos Pharm Ltd | Aminopyrone und ihre verwendung als atm inhibitoren |
| TW200616986A (en) * | 2004-09-20 | 2006-06-01 | Kudos Pharm Ltd | DNA-pk inhibitors |
| JP2008529995A (ja) * | 2005-02-09 | 2008-08-07 | クドス ファーマシューティカルズ リミテッド | Ａｔｍ阻害剤 |
-
2006
- 2006-08-30 TW TW095132010A patent/TW200745094A/zh unknown
- 2006-08-30 US US11/468,315 patent/US20070049588A1/en not_active Abandoned
- 2006-08-30 UY UY29774A patent/UY29774A1/es not_active Application Discontinuation
- 2006-08-31 WO PCT/GB2006/003230 patent/WO2007026157A1/en not_active Ceased
- 2006-08-31 AR ARP060103817A patent/AR056049A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070049588A1 (en) | 2007-03-01 |
| WO2007026157A1 (en) | 2007-03-08 |
| AR056049A1 (es) | 2007-09-12 |
| UY29774A1 (es) | 2007-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200745094A (en) | ATM inhibitor | |
| MY162157A (en) | Substituted indole mcl-1 inhibitors | |
| MX2009009540A (es) | Inhibidores de metaloproteasa que contienen una porcion heterociclica. | |
| TW200738725A (en) | Unsaturated mTOR inhibitors | |
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| TW200716116A (en) | Heteroaryl 11-beta hydroxysteroid dehydrogenase type I inhibitors | |
| EA201290397A1 (ru) | 1,3,4-оксадиазол-2-карбоксамидное соединение | |
| TN2009000049A1 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200745028A (en) | Novel sulphonylpyrroles | |
| SI1940786T1 (sl) | Bifenilni derivati in njihova uporaba pri zdravljenju hepatitisa C | |
| TNSN08191A1 (en) | Kinase inhibitors | |
| TW200716111A (en) | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors | |
| MX2010003565A (es) | Inhibidores de 11-beta hidroxiesteroide deshidrogenasa tipo i de triazolopiridina. | |
| GEP20074236B (en) | Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors | |
| PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
| TW200720271A (en) | DNA-PK inhibitors | |
| WO2006113261A3 (en) | Inhibitors of 11-beta hydroxysteroid dehydrogenase type i | |
| MX2009005795A (es) | Composiciones, sintesis y metodos para usar inhibidores de colinesterasa basados en indanona. | |
| MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| NZ596000A (en) | Carboxamide compounds and their use as calpain inhibitors | |
| EA200970373A1 (ru) | АНТИДЕПРЕССАНТ, НЕЙРОПРОТЕКТОР, ИНГИБИТОР ОТЛОЖЕНИЙ β-АМИЛОИДА ИЛИ СРЕДСТВО, ЗАМЕДЛЯЮЩЕЕ СТАРЕНИЯ, СОДЕРЖАЩИЕ ГЕТЕРОЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ КОНКРЕТНОЙ СТРУКТУРЫ | |
| TW200745027A (en) | Novel sulphonylpyrroles | |
| MX2010008226A (es) | Derivados de difluorobifenilamida para el tratamiento de hipertension ocular. |